z-logo
open-access-imgOpen Access
Spinal neuropeptide Y Y1 receptor-expressing neurons are a pharmacotherapeutic target for the alleviation of neuropathic pain
Author(s) -
Tyler S. Nelson,
Ghanshyam P. Sinha,
Diogo Francisco S. Santos,
Peter Jukkola,
Pranav Prasoon,
Michelle K. Winter,
Kenneth E. McCarson,
Bret N. Smith,
Bradley K. Taylor
Publication year - 2022
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2204515119
Subject(s) - neuropathic pain , sni , allodynia , medicine , nerve injury , hyperalgesia , agonist , neuropeptide y receptor , neuroscience , spinal cord , spinal cord injury , chronic pain , pharmacology , anesthesia , population , neuralgia , nociception , neuropeptide , receptor , chemistry , biology , biochemistry , environmental health , hydrolysis , acid hydrolysis , psychiatry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here